EN DE

Dolby Laboratories, Inc (DLB) Fair Value & Analysis

Industrials · US · Market cap $4.6B

DL Dolby Laboratories, Inc logo Dolby Laboratories, Inc DLB · US
Price$62.37
Fair Value$116.36
Upside+86.6%
Quality77/100
Watch Dolby Laboratories, Inc for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Solidly profitable · 17.9% net margin
Low debt · generates free cash flow
2.82% dividend yield
Ranks above peers (10/15)
Wide moat 73/100
Evidence: High Range $86.20 – $142.71 Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated today

Fair value updated Aug 13, 2026, revised from $52.32 to $116.36 (+122.4%) since Jul 19, 2026. Share price +28.6% over the past month.

A strong business, screening 87% undervalued on our models.

What matters now

  • The rarer combination: high quality (77/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case ($86.20). The market is more pessimistic than our downside scenario.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$94.48 $48.51 Fair Value $116.36 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range $48.51 – $94.48 · fair‑value band $86.20 – $142.71 · the $62.37 price screens below the $116.36 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Dolby Laboratories, Inc (DLB) currently trades at $62.37, while our model-based Fair Value estimate is $116.36, implying the stock looks roughly 86.6% undervalued today. The Quality Score stands at 77/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Dolby Laboratories, Inc generated revenue of $1.4B at a net margin of 17.9%. Revenue grew 7.1% year over year. It earns a return on equity of 9.4%. The balance sheet holds a net cash position of $663M. Fundamentals as of Aug 13, 2026

Our scenario range runs from $86.20 (bear case) to $142.71 (bull case); at $62.37, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -38% fair-value upside, at 87%, DLB screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $88.65 $122.05 $167.37 80
Residual Income $37.48 $41.19 $55.64 76
Rev-Margin DCF $63.35 $87.64 $115.42 74
All 26 models by family
DCF Models
FCF DCF $87.37 $124.91 $178.94 38
Owner Earnings $66.50 $93.69 $132.83 31
5Y Revenue Exit $63.35 $86.76 $115.58 39
5Y EBITDA Exit $84.98 $126.70 $174.47 41
5Y P/E Exit $89.14 $134.39 $181.05 38
10Y Revenue Exit $70.57 $93.54 $122.53 36
10Y EBITDA Exit $85.13 $120.46 $165.95 37
10Y P/E Exit $87.71 $125.64 $170.80 35
Earnings-Based
Graham-Dodd $28.74 $83.88 $110.82 54
Lynch FV $17.45 $24.93 $32.41 50
PEG = 1.0 $17.45 $24.93 $32.41 46
EPV $44.47 $49.65 $54.12 59
Dividend Discount
Gordon GGM $18.42 $36.71 $55.59 70
DDM Multi-Stage $18.42 $29.13 $38.75 61
Multiples
P/E Multiple $88.74 $118.33 $147.91 63
P/S Multiple $53.88 $71.84 $89.80 58
P/B Multiple $53.88 $71.84 $89.80 55
EV/EBIT $90.66 $117.01 $143.35 53
EV/EBITDA $92.96 $120.07 $147.18 54
EV/Revenue $51.59 $68.71 $85.83 43
Asset-Based
NCAV (Graham) $21.73 $29.12 $43.46 50
Growth DCF
Growth DCF $88.65 $122.05 $167.37 80
Rev-Margin DCF $63.35 $87.64 $115.42 74
Economic Profit
Residual Income $37.48 $41.19 $55.64 76
ROIC Compounder $44.70 $52.49 $61.98 72
Growth Earnings
Growth-Adj P/E $70.06 $100.08 $130.11 68

Widest divergence: DCF Models ($120.46) versus Earnings-Based ($24.93). Highest evidence: Growth DCF (80).

Notify me when DLB reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $1.4B
Revenue growth (YoY) +7.1%
Net margin 17.9%
Return on equity 9.4%
Free cash flow $430M FY2025
P/E ratio 21.4 as of Jun 5, 2026
More key figures
Operating margin 29.1%
EPS (TTM) $2.52
Dividend yield 2.6%
EPS growth (YoY) +5.3%
Net cash $663M FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 77/100

Of which business quality 76 · Market factors (momentum, volatility) 45

Profitability 53
Margins and returns on capital today
Quality Growth 39
Are margins and returns improving?
Cashflow 96
Earnings quality: real cash, not paper profit
Fin. Strength 95
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 73
Calm price path (market factor)
Momentum 32
Price trend over the last 3–12 months (market factor)
52W Momentum 36
Distance to the 52-week high (market factor)
Net Issuance 88
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally.

Full company description

Dolby Laboratories, Inc. engages in the design and manufacture of audio, imaging, accessibility, and other hardware and software solutions for television, broadcast, and live entertainment industries in the United States and internationally. The company develops and licenses its audio technologies, such as AAC, HE-AAC, and extended HE-AAC, a digital audio codec solution; AVC, a digital video codec used in STBs, mobile devices, cameras, and broadcast television services and other products; and Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences. It also provides DD+, an advanced surround sound audio codec technology; Dolby AC-4, an audio codec that uses cutting edge compression; and HEVC, a digital video codec that compresses video. In addition, the company offers Dolby Cinemas, a premium large format cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a Dolby theater design; Dolby.io, a SaaS product of immersive, interactive, and social experiences with real-time engagement for live events, especially sports; and digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products for the cinema, television, broadcast, communication, and entertainment industries. Further, it provides various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. It serves film studios, content creators, post-production facilities, and broadcasters. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Dolby Laboratories, Inc reported revenue of $1.3B in FY2025 versus $1.3B in FY2021, a compound +1.3%/yr. Reported net income was $255M in FY2025, compounding −4.8%/yr from FY2021.

Growth Quality 69/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$1.3B
Latest YoY
+5.9%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.0%
Avg. growth/yr (24Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.4%
Revenue +1.3%/yr
FY21 $1.3B
FY22 $1.3B
FY23 $1.0B
FY24 $1.3B
FY25 $1.3B
Net income −4.8%/yr
FY21 $310M
FY22 $184M
FY23 $191M
FY24 $262M
FY25 $255M
Character of growth · EPS growth decomposed (2014-2025) +3.0 % p.a.
Revenue per share +3.0 pp

of which total revenue +2.3 pp · buybacks/dilution +0.7 pp

EBIT margin −1.9 pp
Tax rate +2.4 pp
Residual (interest, one-offs) −0.4 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch DLB: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Dolby Laboratories, Inc Fair Value". https://www.fairvalue-calculator.com/stock/DLB

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Business Services · 250 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 77 · Top 25%
Fair Value upside +87% · Top 25%
Return on equity (TTM) 9% · Above median
Return on assets 5% · Above median
Net margin (TTM) 18% · Top 25%
Operating margin (TTM) 29% · Top 25%
Revenue growth 7% · Above median
Dividend yield (TTM) 2.8% · Above median

Valuation Multiples vs Specialty Business Services median · lower = cheaper

P/E (TTM) 21.4× · Pricier than median
P/B 1.77× · Cheaper than median
P/S (TTM) 3.40× · Pricier than 75% of peers
P/FCF 10.8× · Pricier than median
EV/EBITDA 10.9× · Pricier than median
PEG 2.08× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 28
FUTURE 36 · sector 25
PAST 38 · sector 33
HEALTH 100 · sector 90
DIVIDEND 56 · sector 53

Insider activity: 44/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Cintas Corporation CTAS $205.28 $95.19 -54%
RELX PLC RELX $34.55 $32.24 -7%
Thomson Reuters Corporation TRI C$142.85 C$70.40 -51%
Copart, Inc CPRT $28.99 $28.59 -1%
Global Payments Inc GPN $88.53 $68.98 -22%
RB Global, Inc RBA C$120.52 C$49.14 -59%
Brambles Limited BXB A$19.89 A$12.28 -38%
UL Solutions Inc ULS $76.68 $33.62 -56%
Aramark ARMK $60.35 $13.18 -78%
ISS A/S ISS kr 288.20 kr 251.13 -13%

Compare Dolby Laboratories, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Dolby Laboratories, Inc (DLB) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $116.36 versus a price of $62.37, about +87% (undervalued).
What is the fair value of DLB?
Our model-based fair value for Dolby Laboratories, Inc is $116.36 (as of Aug 13, 2026), built from audited fundamentals. The current price is $62.37.
What is the quality score of DLB?
Dolby Laboratories, Inc has a Quality Score of 77/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Dolby Laboratories, Inc (DLB)?
Dolby Laboratories, Inc reported trailing-twelve-month revenue of about $1.4B (latest available figure, as of Aug 13, 2026).
What is the net profit margin of DLB?
The net profit margin of Dolby Laboratories, Inc is about 17.9%, meaning it keeps roughly 17.9% of revenue as net income. Based on the latest reported figures.
Does Dolby Laboratories, Inc pay a dividend?
Dolby Laboratories, Inc currently shows a dividend yield of about 2.57% relative to its recent price (as of Aug 13, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Dolby Laboratories, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.